ALS, also known as Lou Gehrig's disease, leads to the degeneration of motor neurons, which are responsible for transmitting signals from the brain to voluntary muscles. As these neurons deteriorate, muscle control is lost, leading to weakness and atrophy.
Genetic factors
Approximately 5–10% of ALS cases are familial, meaning they are inherited. Several genetic mutations have been linked to ALS:
- C9orf72: The most common genetic cause, particularly in Europe and North America, involving a hexanucleotide repeat expansion.
- SOD1: Mutations in this gene account for about 12–20% of familial cases.
- TARDBP (TDP-43) and FUS: These genes are involved in RNA processing, and their mutations can lead to protein misfolding and aggregation.
- NEK1 and KIF5A: Recent studies have identified these genes as contributors to ALS risk.
It's important to note that even in sporadic cases (those without a family history), genetic factors may play a role.
Environmental factors
While genetics play a significant role, environmental exposures are also under investigation:
- Military service: Veterans have been found to have a higher incidence of ALS, possibly due to exposure to toxins or physical trauma.
- Exposure to heavy metals and pesticides: Some studies suggest a link between ALS and exposure to substances like lead or certain agricultural chemicals.
- Smoking: Tobacco use has been associated with an increased risk of developing ALS.
- Physical activity: High levels of physical exertion, especially in professional athletes, have been examined as potential risk factors.
However, it's crucial to understand that these associations do not imply causation, and more research is needed to establish definitive links.

The interplay between genetics and environment
Current research suggests that ALS may result from a complex interaction between genetic predispositions and environmental exposures. For instance, an individual with a genetic mutation might only develop ALS upon encountering specific environmental triggers. This multifactorial model underscores the disease's complexity and the challenges in pinpointing a singular cause.
Ongoing research and future directions
Scientists continue to explore various avenues to better understand ALS:
- Biomarker identification: Detecting biological markers that indicate disease presence or progression.
- Gene therapy: Developing treatments that target specific genetic mutations.
- Stem cell research: Investigating the potential of stem cells to replace damaged motor neurons.
These efforts aim to uncover more about ALS's origins and pave the way for effective treatments.
Considering future options: cryopreservation
Facing an ALS diagnosis can be overwhelming, especially given the current limitations in treatment options. In such scenarios, exploring future-oriented possibilities becomes essential.
At Tomorrow.bio, we offer human cryopreservation—a process of preserving individuals at low temperatures after legal death, with the hope that future medical advancements may allow for revival and treatment. While not a cure, it represents an opportunity to bridge today's limitations and tomorrow's possibilities.
We understand the emotional weight of a terminal diagnosis. Our team is here to provide information and support, helping you make informed decisions about your future.
Related articles
About Tomorrow.bio
At Tomorrow.bio, we are dedicated to advancing the science of cryopreservation with the goal of giving people a second chance at life. As Europe’s leading human cryopreservation provider, we focus on rapid, high-quality standby, stabilization, and storage of terminal patients—preserving them until future medical technologies may allow revival and treatment.
Our mission is to make human cryopreservation a reliable and accessible option for everyone. We believe that no life should end because current medical capabilities fall short.
Our vision is a future where death is optional—where people have the freedom to choose long-term preservation in the face of terminal illness or fatal injury, and to awaken when medicine has caught up.
Interested in learning more or becoming a member?
📧 Contact us at: hello@tomorrow.bio
🌐 Visit our website: www.tomorrow.bio
🤝 Schedule a call with our team: Book a call